Drug Type Therapeutic vaccine |
Synonyms TVAX 008, TVAX008 |
Target |
Mechanism HBcrAg inhibitors(HBcrAg inhibitors), L-HBsAg inhibitors(L-HBsAg inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationBreakthrough Therapy (CN) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B, Chronic | Phase 2 | CN | 30 May 2023 |